Tigermed
Peter W. has a diverse work experience spanning multiple industries. Peter is currently the Vice President of Business Development at Hangzhou Tigermed Consulting Co., Ltd, a position they have held since May 2023. Prior to this role, they worked at the same company as the Business Development and Marketing Senior Director, where they played a crucial role in implementing sales plans and establishing strong relationships with clients.
Before joining Hangzhou Tigermed Consulting Co., Ltd, Peter worked as the Head of Marketing and Medical at Health Vision Enterprise Limited from September 2013 to March 2015. Peter also served as the Marketing Strategic Director at Simcere Pharmaceutical Group from January 2012 to August 2013.
Peter's experience in the pharmaceutical industry includes their time at Roche Pharmaceuticals, where they held multiple roles. Peter was the Group Product Manager from September 2008 to December 2011, overseeing marketing efforts in the fields of nephrology and osteoporosis. Additionally, they served as a Product Manager from August 2004 to August 2008 and started their career at Roche Pharmaceuticals as a Medical Marketing Specialist from August 2002 to July 2004.
Overall, Peter has a solid background in business development, marketing, and management in the healthcare and pharmaceutical sectors, with extensive experience in sales planning, relationship building, team management, and strategic analysis.
Peter W. began their education in 1993 at Harbin Medical University, where they obtained a Bachelor of Medicine degree in Clinical medicine after completing the program in 2001. During the same period, they also attained a Medical Master degree in Clinical medicine from Harbin Medical University.
In 2018, Peter W. enrolled in the EMBA program at the Management School of Fudan University. Peter pursued their studies in high-level industrial and commercial management and is expected to complete the program in 2021. It is worth noting that this represents a duplicate entry of their education history.
This person is not in any offices
Tigermed
1 followers
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees across 50 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibilities for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.